Harbin Gloria Pharmaceuticals (002437.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000QG8
Harbin Gloria Pharmaceuticals financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.44 bn CNY | 2.14 bn CNY |
| Gross profit | 1.30 bn CNY | 968.37 m CNY |
| Operating income | 284.85 m CNY | 268.78 m CNY |
| EBIT | 293.72 m CNY | 412.10 m CNY |
| Net income | 232.76 m CNY | 376.91 m CNY |
| Diluted EPS – continuing operations | 0.10 CNY | 0.17 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Harbin Gloria Pharmaceuticals
HARBIN GLORIA PHARMACEUTICALS Co., LTD, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamin supplements, electrolyte drugs, hypoglycemic drugs, analgesics, digestive system and metabolic drugs, anti-infective drugs, and anti-tumor drugs. It also provides deer antler polypeptide injections, Annao pills and tablets, potassium chloride sustained-release tablets, sodium creatine phosphate for injection, ginkgo biloba extract injections, vitamins (B12), fluorouracil for injection, bleomycin hydrochloride for injection, and other injectable products, as well as pravastatin sodium tablets, olmesartan medoxomil amlodipine tablets, and edoxaban tosylate tablets. In addition, the company engages in pharmaceutical promotion; project investment; investment services; trade import and export; wholesale and retail; and technology promotion and application services. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is headquartered in Harbin, the People's Republic of China.
More stocks
- Shenzhen Boshijie Technology Co., Ltd. (301608.SZ)
- WuXi Xinje Electric Co Ltd (603416.SS)
- Shanghai Hajime Advanced Material Technology Co. Ltd. (301000.SZ)
- XPS Pensions Group PLC (XPS.L)
- Ceribell, Inc. (CBLL)
- Jinzi Ham Co Ltd (002515.SZ)
- Hotel101 Global Holdings Corp. Class A Ordinary Shares (HBNB)
- Mission Produce, Inc. (AVO)
- Labrador Iron Ore Royalty Corp (LIF.TO)
- Xian Xice Testing Technology Co. Ltd. A (301306.SZ)
- Hartalega Holdings Bhd (5168.KL)
- Hunan Huakai Cultural and Creative Co Ltd (300592.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.